Epigenomics AG
Records under this name other than patents Epigenomics AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,385,402 | Methods and nucleic acids for analyses of cellular proliferative disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,749,702 | Methods and nucleic acids for the analyses of cellular proliferative disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,951,563 | Methods and nucleic acids for analysis of cellular proliferative disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,605,306 | Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,017,944 | Methods for the Prognosis of Breast Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,912,129 | Method for the determination of the DNA methylation level of a CPG position in identical cells within a tissue sample Formerly held In force · High confidence | In force | High confidence | |
| US 10,731,215 | Method for determining the presence or absence of methylation in a sample Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,053,735 | Markers for the prediction of outcome of anthracycline treatment Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,110,558 | Methods and Nucleic Acids for Determining the Prognosis of a Cancer Subject Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,626,462 | Methods and Nucleic Acids for Determining the Prognosis of a Cancer Subject Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence |